hypercoagulable
[용어속성] Term
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)
코로나바이러스 질환 2019(COVID-19) 환자의 프로트롬빈 단편 1.2 평가
Article
[키워드] 95% CI
Activation
adjusted
adjusted odds ratio
Analysis
association
characteristic
Coagulation
coronavirus disease
Coronavirus disease 2019
COVID-19
Critically ill
D-dimer
described
develop
diagnosing
dimer
elevated
Elevation
evaluate
evaluated
Hospitalization
Hospitalized
hospitalized patient
hospitalized patients
hypercoagulable
Hypercoagulable state
Laboratory
likelihood ratio
manifestation
marker
multivariable analysis
multivariable logistic regression
Odds ratio
Patient
performed
positive
positively correlated
receiver operating characteristic
ROC
ROC analysis
sensitivity
significantly
specificity
threshold
thrombosis
thrombotic
VTE
with COVID-19
[DOI] 10.1002/ajh.25962 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/ajh.25962 PMC 바로가기 [Article Type] Article
Large Vessel Occlusion Secondary to COVID-19 Hypercoagulability in a Young Patient: A Case Report and Literature Review
젊은 환자의 COVID-19 과응고성에 따른 대혈관 폐색: 증례 보고 및 문헌 검토
Review
[키워드] abnormality
acute respiratory syndrome
acute respiratory syndrome coronavirus
Admission
affected
African American
aortic arch
Atrial fibrillation
average
cardiac thrombus
cardiac tumor
Cardiomyopathy
carotid
carotid artery
Cerebral artery
clinically
Coagulopathy
complications
Coronavirus-2
correlation
COVID-19
COVID-19 infection
cubic
D-dimer
D-dimer level
disease
Dissection
edema
elevated
Evidence
evidence of
fibrinogen
Final
Foramen ovale
highlight
Hospitalization
hypercoagulability
hypercoagulable
Hypercoagulable state
IgM
increasingly
Infarction
Infection
internal carotid artery
Large vessel occlusion
literature
marker
Mechanical
middle cerebral artery
no evidence of
normal values
Occlusion
on admission
outcome
Patent foramen ovale
Patient
patients with COVID-19
proximal
pulmonary symptoms
reached
recognizing
reperfusion
report
respiratory
resulting
review
SARS-CoV-2
secondary to
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
stenosis
stroke
thromboembolic
to define
valvular
Vascular
vessel
with COVID-19
Young patient.
[DOI] 10.1016/j.jstrokecerebrovasdis.2020.105307 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.jstrokecerebrovasdis.2020.105307 PMC 바로가기 [Article Type] Review
Neurological emergencies associated with COVID-19: stroke and beyond
Case Reports
[키워드] COVID-19
hypercoagulable
MRI
neurological
neurotropism
[DOI] 10.1007/s10140-020-01837-7 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1007/s10140-020-01837-7 PMC 바로가기 [Article Type] Case Reports
Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke
Observational Study
[키워드] addition
Admission
affected
age
Atypical
baseline
cardiovascular risk factors
collected
conducted
coronavirus disease
COVID
COVID-19
COVID-19 infection
COVID-19 pandemic
endothelial damage
etiology
Follow-up
functional
hospital
hypercoagulable
Ischemic
male
mechanism
Occlusion
outcome
Patient
patients with COVID-19
phenotype
presenting
raise
remained
Retrospective study
stroke
systemic
thrombosis
thrombus burden
Undetermined
vessel
vessels
with COVID-19
[DOI] 10.3174/ajnr.A6799 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3174/ajnr.A6799 PMC 바로가기 [Article Type] Observational Study
Acute limb ischemia in patients with COVID-19 pneumonia
Observational Study
[키워드] 24 hours
absence
Acute limb ischemia
age
Characteristics
Clinical outcome
collected
complications
coronavirus
COVID-19
COVID-19 pandemic
database
death
defined
determine
diagnosis of COVID-19
died
Efficacy
eight
evaluated
expected
greater
hospital
hypercoagulable
IMPROVE
incidence
incidence rate
Infection
intravenous
Ischemia
Italian
limb
lombardy
men
Novel coronavirus
Observational cohort study
Older
operative treatment
pandemic
Patient
patients
patients with COVID-19
performed
Pneumonia
positive
postoperative
presenting
Primary outcome
required
revascularization
significantly
significantly increased
single-center
surgical
survival
tested
treated
Treatment
was performed
women
[DOI] 10.1016/j.jvs.2020.04.483 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.jvs.2020.04.483 PMC 바로가기 [Article Type] Observational Study
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Clinical Trial
[키워드] activated partial thromboplastin time
acute respiratory distress syndrome
Anticoagulant
Anticoagulant treatment
anticoagulation
aPTTactivated partial thromboplastin time
ARDSacute respiratory distress syndrome
assigned
autopsy study
baseline
BMIbody mass index
body mass index
cause
Chronic Kidney Disease Epidemiology Collaboration
CIconfidence interval
circulation
CKD-EPIChronic Kidney Disease Epidemiology Collaboration
clinical trial
Coagulopathy
confidence interval
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19coronavirus disease 2019
CrClcreatinine clearance
creatinine clearance
D-dimer
decrease
DICdisseminated intravascular coagulation
Disseminated intravascular coagulation
evaluated
FiO2
FiO2fraction of inspired oxygen
fraction
fraction of inspired oxygen
Gas exchange
hypercoagulable
ICUIntensive Care Unit
IMPROVE
increase in
intensive care unit
interquartile range
IQR
IQRinterquartile range
LMWHlow molecular weight heparin
low molecular weight heparin
Mechanical
mechanical ventilation
microthrombi
observé
Open-label
oxygen
PaO2
PaO2/FiO2 ratio
PaO2partial pressure of arterial oxygen
partial pressure of arterial oxygen
Patient
PEEPpositive end-expiratory pressure
Positive end-expiratory pressure
Prophylactic
randomization
Randomized
receive
reverse transcriptase-polymerase chain reaction
RT-PCRreverse transcriptase-polymerase chain reaction
SAPS3simplified acute physiology score 3
sepsis-induced coagulopathy score
sequential organ failure assessment score
severe COVID-19
SICsepsis-induced coagulopathy score
simplified acute physiology score 3
SOFAsequential organ failure assessment score
statistically significant
therapeutic
Thromboprophylaxis
UFHunfractionated heparin
ULNupper limit of normal
unfractionated heparin
upper limit of normal
Ventilation
ventilator-free day
Ventilator-free days
[DOI] 10.1016/j.thromres.2020.09.026 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/j.thromres.2020.09.026 PMC 바로가기 [Article Type] Clinical Trial
Acute portal vein thrombosis secondary to COVID-19: a case report
Case Report
[키워드] abdominal pain
anticoagulation
asthmatic
Case report
cause
clinician
complications
Coronavirus pneumonia
Coronaviruses
COVID-19
disease
exhibit
hypercoagulable
lab
male
Mild
patients with COVID-19
Pneumonia
Portal vein
routine
the patient
therapy
thrombosis
[DOI] 10.1186/s12876-020-01518-2 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s12876-020-01518-2 PMC 바로가기 [Article Type] Case Report
COVID ‐19, thromboembolic risk, and Virchow’s triad: Lesson from the past
Review
[키워드] Acute myocardial infarction
acute pulmonary embolism
Blood
blood stasis
COVID
COVID‐19
COVID‐19 patients
COVID‐19
described
diagnostic
drug
element
endothelial injury
Evidence
explain
Factor
feature
highlight
hypercoagulability
hypercoagulable
immune system
Infection
lesson
manifestation
outlined
placental thrombosis
Pneumonia
Respiratory disease
SARS‐CoV‐2
stroke
Symptom
systemic arterial embolism
thromboembolic
thromboembolic risk
Thromboembolism
thrombosis
Treatment
unique
variety
venous
[DOI] 10.1002/clc.23460 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/clc.23460 PMC 바로가기 [Article Type] Review
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19
COVID-19 환자의 응고병증, 정맥 혈전색전증 및 항응고제
Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
Anticoagulant
anticoagulant therapy
anticoagulation
clinician
Coagulopathy
Consensus
coronavirus
COVID-19
demonstrated
expected
hypercoagulable
Infection
Inflammatory
information
intensity
intensive care patient
intensive care patients
international organization
list
observational studies
observational study
pathophysiology
Patient
patients with COVID-19
produced
Prophylaxis
Randomized controlled trial
referred to
respiratory
Respiratory disease
respiratory distress
risk
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
subsequent
syndrome
the disease
therapy
thrombosis
thrombotic
Treatment
Venous Thromboembolism
VTE
was performed
with COVID-19
worldwide pandemic
[DOI] 10.1002/phar.2465 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/phar.2465 PMC 바로가기 [Article Type] Review